cysview- hexaminolevulinate hydrochloride
photocure inc - hexaminolevulinate hydrochloride (unii: d4f329sl1o) (hexaminolevulinate - unii:g7h20tki67) - hexaminolevulinate hydrochloride 100 mg in 50 ml - cysview is an optical imaging agent indicated for use in the cystoscopic detection of non-muscle invasive papillary cancer of the bladder among patients suspected or known to have lesion(s) on the basis of a prior cystoscopy. cysview is used with the karl storz d-light c photodynamic diagnostic (pdd) system to perform cystoscopy with the blue light setting (mode 2) as an adjunct to the white light setting (mode 1). cysview is not: - a replacement for random bladder biopsies or other procedures used in the detection of bladder cancer [see warnings and precautions (5.2) ]. - for repetitive use. the potential risks associated with repetitive exposure, including sensitization and adverse effects of blue light have not been evaluated [see warnings and precautions (5.1) ]. cysview is contraindicated in patients with: - porphyria - gross hematuria - bcg immunotherapy or intravesical chemotherapy within the past 90 days - known hypersensitivity to hexaminolevulinate or any derivative of aminolevulinic acid pregnancy
cysview- hexaminolevulinate hydrochloride kit
photocure inc. - hexaminolevulinate hydrochloride (unii: d4f329sl1o) (hexaminolevulinate - unii:g7h20tki67) - hexaminolevulinate hydrochloride 100 mg in 50 ml - cysview is indicated for use in the cystoscopic detection of carcinoma of the bladder, including carcinoma in situ (cis), among patients suspected or known to have lesion(s) on the basis of a prior cystoscopy, or in patients undergoing surveillance cystoscopy for carcinoma of the bladder. cysview is used with the karl storz d-light c photodynamic diagnostic (pdd) system to perform blue light cystoscopy (blc ® ) as an adjunct to the white light cystoscopy. cysview is not a replacement for random bladder biopsies or other procedures used in the detection of bladder cancer [ see warnings and precautions (5.2) ]. cysview is contraindicated in patients with: - porphyria, - gross hematuria, - known hypersensitivity to hexaminolevulinate or any derivative of aminolevulinic acid. risk summary there are no available data on cysview use in pregnant women to inform a drug associated risk of adverse developmental outcomes. adequate reproductive and developmental toxicity studie
hexvix hexaminolevulinate (as hydrochloride) 85 mg powder for intravesical solution vial plus diluent vial
juno pharmaceuticals pty ltd - hexaminolevulinate hydrochloride -
hexvix hexaminolevulinate (as hydrochloride) 85 mg powder for intravesical solution vial plus diluent vial
endotherapeutics pty ltd - hexaminolevulinate hydrochloride, quantity: 100 mg (equivalent: hexaminolevulinate, qty 85 mg) - diluent, not applicable - excipient ingredients: sodium hydroxide; dibasic sodium phosphate dihydrate; monobasic potassium phosphate; sodium chloride; water for injections; hydrochloric acid - this medicinal product is for diagnostic use only.,hexvix blue light fluorescence cystoscopy is indicated as adjunct to standard white light cystoscopy to contribute to the diagnosis and management of bladder cancer in patients with known or high suspicion of bladder cancer.
hexvix 85 mg, powder and solvent for intravesical solution
ipsen pharmaceuticals limited - hexaminolevulinate hydrochloride - pdr+solv/soln/intravesical use - 85 milligram(s) - other diagnostic agents
hexvix 85mg powder and solvent for intravesical solution vials
photocure asa - hexaminolevulinate hydrochloride - powder and solvent for intravesical solution - 85mg
hexvix 85 mg, powder and solvent for intravesical solution
photocure asa - hexaminolevulinate hydrochloride - powder and solvent for intravesical solution - 85 milligram(s) - other diagnostic agents
hexvix 85 mg i.vesic. sol. (pwdr. + solv.) vial
photocure asa - hexaminolevulinate hydrochloride 100 mg - eq. hexaminolevulinate 85 mg - powder and solvent for intravesical solution - 85 mg - hexaminolevulinate hydrochloride - other diagnostic agents
hexvix
endotherapeutics nz limited - hexaminolevulinate hydrochloride 100mg equivalent to hexaminolevulinate 85mg - powder for injection - 85 mg - active: hexaminolevulinate hydrochloride 100mg equivalent to hexaminolevulinate 85mg excipient: dibasic sodium phosphate dihydrate hydrochloric acid monobasic potassium phosphate sodium chloride sodium hydroxide water for injection - hexvix® is indicated for diagnostic use only. hexvix blue light fluorescence cystoscopy is indicated as adjunct to standard white light cystoscopy to contribute to the diagnosis and management of bladder cancer in patients with known or high suspicion of bladder cancer.
hexvix 85mg, powder and solvent for intravesical solution
ipsen m.e.p.e ag. dimitriou 63 alimos, 17456 athens, greece - hexaminolevulinate - powder and solvent for solution for intravesical use - hexaminolevulinate 85 mg - diagnostic agents